Kangyuan Pharmaceutical announced that it recently received the “Drug Clinical Trial Approval Notice” for Qihuangzhengqi granules issued by the State Drug Administration. Qihuang Zhengqi granules are clinical empirical formulations formed under the theoretical guidance of traditional Chinese medicine. They have the effect of improving qi and blood nourishment, and correcting deficiency, and are used to treat symptoms of cancer-induced fatigue, qi and blood deficiency.

Kangyuan Pharmaceutical announced that it recently received the “Drug Clinical Trial Approval Notice” for Qihuangzhengqi granules issued by the State Drug Administration. Qihuang Zhengqi granules are clinical empirical formulations formed under the theoretical guidance of traditional Chinese medicine. They have the effect of improving qi and blood nourishment, and correcting deficiency, and are used to treat symptoms of cancer-induced fatigue, qi and blood deficiency.